IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation

NCT01050478 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Psychomotor Agitation
Acute Disease

Interventions

DRUG: Paliperidone ER
DRUG: Benzodiazepine

Sponsor

Janssen Cilag N.V./S.A.